Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria. Chung, J; Anderson, SA; Gwynn, B; Deck, KM; Chen, MJ; Langer, NB; Shaw, GC; Huston, NC; Boyer, LF; Datta, S; Paradkar, PN; Li, L; Wei, Z; Lambert, AJ; Sahr, K; Wittig, JG; Chen, W; Lu, W; Galy, B; Schlaeger, TM; Hentze, MW; Ward, DM; Kaplan, J; Eisenstein, RS; Peters, LL; Paw, BH The Journal of biological chemistry
289
7835-43
2014
Kivonat megmutatása
Mitochondrial iron is essential for the biosynthesis of heme and iron-sulfur ([Fe-S]) clusters in mammalian cells. In developing erythrocytes, iron is imported into the mitochondria by MFRN1 (mitoferrin-1, SLC25A37). Although loss of MFRN1 in zebrafish and mice leads to profound anemia, mutant animals showed no overt signs of porphyria, suggesting that mitochondrial iron deficiency does not result in an accumulation of protoporphyrins. Here, we developed a gene trap model to provide in vitro and in vivo evidence that iron regulatory protein-1 (IRP1) inhibits protoporphyrin accumulation. Mfrn1(+/gt);Irp1(-/-) erythroid cells exhibit a significant increase in protoporphyrin levels. IRP1 attenuates protoporphyrin biosynthesis by binding to the 5'-iron response element (IRE) of alas2 mRNA, inhibiting its translation. Ectopic expression of alas2 harboring a mutant IRE, preventing IRP1 binding, in Mfrn1(gt/gt) cells mimics Irp1 deficiency. Together, our data support a model whereby impaired mitochondrial [Fe-S] cluster biogenesis in Mfrn1(gt/gt) cells results in elevated IRP1 RNA-binding that attenuates ALAS2 mRNA translation and protoporphyrin accumulation. | 24509859
|
Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Shah, DI; Takahashi-Makise, N; Cooney, JD; Li, L; Schultz, IJ; Pierce, EL; Narla, A; Seguin, A; Hattangadi, SM; Medlock, AE; Langer, NB; Dailey, TA; Hurst, SN; Faccenda, D; Wiwczar, JM; Heggers, SK; Vogin, G; Chen, W; Chen, C; Campagna, DR; Brugnara, C; Zhou, Y; Ebert, BL; Danial, NN; Fleming, MD; Ward, DM; Campanella, M; Dailey, HA; Kaplan, J; Paw, BH Nature
491
608-12
2011
Kivonat megmutatása
Defects in the availability of haem substrates or the catalytic activity of the terminal enzyme in haem biosynthesis, ferrochelatase (Fech), impair haem synthesis and thus cause human congenital anaemias. The interdependent functions of regulators of mitochondrial homeostasis and enzymes responsible for haem synthesis are largely unknown. To investigate this we used zebrafish genetic screens and cloned mitochondrial ATPase inhibitory factor 1 (atpif1) from a zebrafish mutant with profound anaemia, pinotage (pnt (tq209)). Here we describe a direct mechanism establishing that Atpif1 regulates the catalytic efficiency of vertebrate Fech to synthesize haem. The loss of Atpif1 impairs haemoglobin synthesis in zebrafish, mouse and human haematopoietic models as a consequence of diminished Fech activity and elevated mitochondrial pH. To understand the relationship between mitochondrial pH, redox potential, [2Fe-2S] clusters and Fech activity, we used genetic complementation studies of Fech constructs with or without [2Fe-2S] clusters in pnt, as well as pharmacological agents modulating mitochondrial pH and redox potential. The presence of [2Fe-2S] cluster renders vertebrate Fech vulnerable to perturbations in Atpif1-regulated mitochondrial pH and redox potential. Therefore, Atpif1 deficiency reduces the efficiency of vertebrate Fech to synthesize haem, resulting in anaemia. The identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development. An ATPIF1 deficiency may contribute to important human diseases, such as congenital sideroblastic anaemias and mitochondriopathies. | 23135403
|